Inhibition of dipeptidyl peptidase 9 improves sorafenib sensitivity by inducing ferroptosis in hepatocellular carcinoma
Inhibition of DPP9 improves sorafenib sensitivity by promoting ferroptosis in HCC, which provides novel evidence for DPP9 as an HCC treatment target synergizing with sorafenib.
Authors
- Jun Zou (ORCID: https://orcid.org/0000-0002-0112-5118)
- Q. Li (ORCID: https://orcid.org/0000-0003-2902-1350)
- Yang Wang (ORCID: https://orcid.org/0000-0003-4423-9235)
Institutions
- Hubei University of Chinese Medicine (CN)
- Shandong Institute of Food and Drug Inspection (CN)
- ZheJiang Institute For Food and Drug Control (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Journal of Cancer Research and Clinical Oncology
- Published
- 2025-09-09
- DOI
- https://doi.org/10.1007/s00432-025-06300-z
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00